Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications

By Correa R.C.   Alfieri A.B.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 5, 2003-09 ,pp. : 264-268

Elsevier

Access to resources Recommend Favorite

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes

By Hyvönen Mervi   Ihalmo Pekka   Sandholm Niina   Stavarachi Monica   Forsblom Carol   McKnight Amy   Lajer Maria   Maestroni Anna   Lewis Gareth   Tarnow Lise   Maestroni Silvia   Zerbini Gianpaolo   Parving Hans-Henrik   Maxwell Alexander   Groop Per-Henrik   Lehtonen Sanna  

Acta Diabetologica, Vol. 50, Iss. 6, 2013-12 ,pp. : 887-897

Springer Publishing Company

Access to resources Recommend Favorite

Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes

By Kralik Patricia   Ye Gang   Metreveli Naira   Shen Xia   Epstein Paul  

Cardiovascular Toxicology, Vol. 5, Iss. 3, 2005-09 ,pp. : 285-292

Humana Press, Inc

Access to resources Recommend Favorite

Autonomic dysfunction and microvascular damage in systemic sclerosis

By Franco Manuela   Paradiso Michele   Riccieri Valeria   Basili Stefania   Mammarella Antonio   Valesini Guido  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1278-1283

Springer Publishing Company

Access to resources Recommend Favorite

Mineralocorticoid Receptor-Associated Hypertension and Target Organ Damage: Clinical Relevance for Resistant Hypertension in End Stage Renal Disease

By  

Current Hypertension Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 267-275

Bentham Science Publishers

Access to resources Recommend Favorite